Stig Ola Winqvist

Board of Directors, ITH Immune Therapy Holdings AB

Svankärrsvägen 32 FSE13 active roles

Stig Ola Winqvist er SE direktør med 13 aktive roller på tværs af Swedish-selskaber, herunder Board of Directors hos ITH Immune Therapy Holdings AB.

Overview

Aktive roller

bestyrelse og ledelse

Tidligere roller

tidligere stillinger

Opløste selskaber

i bestyrelseshistorik

2024 – now
Board of Directors, Bostadsrättsföreningen Loket 23
2023 – now
Board of Directors, Immuvance AB
2023 – 2023
Deputy Board Member, Takura AB
2023 – 2023
Chief Executive Officer, CarryGenes Therapeutics AB
2022 – now
Board of Directors, ImmunoWise AB
2022 – now
Chief Executive Officer, ISR Immune System Regulation AB
2022 – now
Chief Executive Officer, ISR Immune System Regulation Holding AB (publ)
2022 – now
Chief Executive Officer, ISR Vaccine AB
2022 – now
Board of Directors, Immunowise Investment AB
2022 – now
Owner, ImmunoLogic Europe Handelsbolag
2022 – 2024
Chief Executive Officer, CarryGenes General Partners AB
2021 – now
Chief Executive Officer, ISR HBV Technology AB
2020 – now
Board of Directors, ITH Immune Therapy Holdings AB
2020 – now
Board of Directors, TLA Targeted Immunotherapies AB
2020 – now
Chief Executive Officer, ISR Oncology AB
2020 – now
Board of Directors, Tinnovate AB
2020 – 2023
Chief Executive Officer, CarryGenes Oncology AB

Nationalitet

Adresse

Svankärrsvägen 32 F